The 4 analysts offering 12-month price forecasts for Applied Therapeutics Inc have a median target of 11.00, with a high estimate of 23.00 and a low estimate of 2.25. The median estimate represents a +1,070.21% increase from the last price of 0.94.
The current consensus among 5 polled investment analysts is to Buy stock in Applied Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.45
Reporting Date Nov 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.